Related Product Information
Description
DMRIE-C Reagent is suitable for the transfection of DNA (1,2) and RNA (3,4) into eukaryotic cells, and is particularly effective for transfection of suspension cells (e.g. Jurkat) and other lymphoid-derived cell lines. Refer t the Cell Lines database at www.invitrogen.com for a list of cell types successfully transfected. DMRIE-C can also be used for in vivo delivery of DNA (5). DMRIE-C is a 1:1 (M/M) liposome formulation of the cationic lipid DMRIE (1,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl ammonium bromide) (6) and cholesterol in membrane filtered water.
Important Guidelines for Transfection
- Form complexes using the amounts of DNA (or RNA) and DMRIE-C recommended. Optimize as necessary. Note: We recommend diluting DNA (or RNA) and DMRIE-C into Opti-MEM® I Reduced Serum Medium (Cat. No. 31985-062) before complexing.
- DMRIE-C is a lipid suspension that may settle with time. Mix thoroughly by inverting the tube 5-10 times before use.
- Transfect cells at the confluence or cell density recommended. Optimize as necessary. Maintain the same seeding conditions between experiments.
- Do not add antibiotics to media during transfection as this causes cell death.
- For optimal results, perform transfection in medium without serum. Cells may be transfected in the presence of serum, if desired; however, complexes must be formed in serum-free medium.
- Test serum-free media for compatibility with DMRIE-C since some serum-free formulations (e.g., CD 293, 293 SFM II, VP-SFM) may inhibit cationic lipid-mediated transfection.
- Procedures are provided to transfect cells in a 6-well format (60-mm format for stable transfection with DNA). For other formats, vary the amounts of DNA (or RNA), DMRIE-C, cells, and medium used in proportion to the relative surface area of the tissue culture vessel.
This product is distributed for laboratory research only. CAUTION: Not for diagnostic use. The safety and efficacy of this product in diagnostic or other clinical uses has not been established.
- One day before transfection, plate cells in growth medium without antibiotics such that they will be at the recommended confluence at the time of transfection.
- For each transfection sample, prepare complexes as follows:
- a. Dilute 1-2 μg of DNA in 500 μl (1 ml for stable transfection) of Opti-MEM® I Reduced Serum Medium (or other medium) without serum.
- b. Mix DMRIE-C before use, then dilute 2-12 μl of DMRIE-C in 500 μl (1 ml for stable transfection) of Opti-MEM® I Medium (or other medium) without serum. Let stand at room temperature for 30-45 minutes.
- c. Combine the diluted DNA with diluted DMRIE-C (total volume = 1 ml; 2 ml for stable transfection). Mix gently and incubate for 15-45 minutes at room temperature (solution may appear cloudy).
- Remove the growth medium from the cells and wash once with 2 ml of= growth medium without serum. Remove the wash medium.
- Add the complexes (Step 2c) to cells. Mix gently by rocking the plate back and forth.
- Incubate cells at 37°C in a CO2 incubator for 4-24 hours.
- Replace the medium with 2 ml of growth medium containing serum (4 ml for stable transfection). Alternatively, add 1 ml of growth medium containing 2X the normal concentration of serum (2 ml for stable transfection) without removing the DNA-containing medium.
- Transient: Test for transgene expression 24-72 hours post-transfection. Stable cell lines: Passage cells at a 1:5 (or higher dilution) into selective medium 48-72 hours post-transfection.
Condition | Cell no. | Growth med. vol. | Format | Confluence at txfn |
---|---|---|---|---|
Transient | 1-2 x 105 | 2 ml | 6-well | 60-80% |
60-80% | 1-2 x 105 | 4 ml | 60-mm | 30-50% |
- Use the following procedure to transfect mammalian cells in suspension in a 6-well format. All amounts and volumes are given on a per well basis.
- For each transfection sample, prepare complexes as follows:
- a. Aliquot 500 μl of Opti-MEM® I Reduced Serum Medium (or other medium) without serum into a well. Mix DMRIE-C before use, then dilute 2-12 μl into the medium, and mix gently by swirling the plate.
- b. In a 12 x 75 mm polystyrene tube, dilute 4 μg of DNA in 500 μl of Opti-MEM® I Medium (or other medium) without serum.
- c. Add the diluted DNA to the well containing diluted DMRIE-C (total volume = 1 ml). Mix by swirling the plate and incubate for 15-45 minutes at room temperature (solution may appear cloudy).
- While complexes are forming, prepare a single cell suspension from stock cells. Wash the cells once with serum-free growth medium without antibiotics, and add 2-3 x 106 cells in 0.2 ml of serum-free growth medium without antibiotics to each well.
- Incubate cells at 37°C in a CO2 incubator for 4-5 hours.
- Add 2 ml of growth medium containing 15% fetal bovine serum to the cells. Note: For Jurkat and MOLT-4 cells, add 1 μg/ml PMA and 50 ng/ml PHA, if desired, to enhance promoter activity and gene expression. For K562 and KG-1 cells, add PMA alone.
- Test for transgene expression 24-48 hours post-transfection.
- One day before transfection, plate 2-3 x 105 cells in 2 ml of growth medium without antibiotics such that they will be 80% confluent at the time of transfection.
- Just before transfection, remove the growth medium from the cells and wash once with 2 ml of growth medium without serum. Remove wash medium. Proceed to Step 3.
- For each transfection sample, prepare complexes as follows:
a. To a 12 x 75 mm polystyrene tube, add 1 ml of Opti-MEM® I Medium (or other medium) without serum. Mix DMRIE-C before use, then dilute 2-12 μl into the medium. Mix or vortex briefly. - b. Add 2-5-5 μg of RNA into the tube containing DMRIE-C and medium (Step 3a). Mix or vortex briefly, then immediately add complexes to washed cells.
- Incubate at 37°C in a CO2 incubator for 4 hours, then replace transfection medium with complete growth medium.
- Assay for expression of transfected RNA 16-24 hours post-transfection. Note: Capped and polyadenylated mRNA is translated more efficiently and is more stable within the cell.
Quality Control
DMRIE-C is tested for the absence of microbial contamination using blood agar plates, Sabouraud dextrose agar plates, and fluid thioglycolate medium, and functionally by transfection of Jurkat cells with a reporter plasmid. DMRIE-C is also tested for the absence of RNase activity using globin mRNA as a substrate.
2. Macdonald, A.S., et al. (1996) Focus® 18, 6.
3. Ciccarone, V., et al. (1994) Focus® 16, 94.
4. Schifferli, K.P. and Ciccarone, V. (1996) Focus® 18,45.
5. Logan, J.J., et al. (1995) Gene Therapy 2, 38.
6. Felgner, J.H., et al. (1994) J. Biol. Chem. 269, 2550.